Why do mental health professionals diagnose mental illness by medical observation and not by something more definitive like a blood test or a brain scan? It’s often pointed out that illnesses like cancer or diabetes have blood or urine tests, scans, and so forth. So why not mental health issues? Join us as our host asks these questions and discusses the state of genomic research with the executive director of the National Institute of Mental Health, Dr. Joshua A. Gordon. Dr. Gordon shares current research, explains the limits of scientific testing, and answers why there isn’t a more definitive test for disorders like bipolar, depression, schizophrenia, and so on. “Simplifying can be useful because it helps us understand fundamental concepts. Genes cause mental illness. That's true, right? But it's also not wholly accurate. It doesn't tell the whole story. The whole story is genes contribute to mental illness, but so does trauma. So does infection in pregnancy. So does stress because you lost a job. All those different things contribute to mental illness. We have to be able to let some of that complexity. Because if all that we do is focus on genes, we're going to be missing a big part of the story.” ~Dr. Joshua A. Gordon To learn more -- or read the transcript -- please visit the official episode page. Our guest, Joshua A. Gordon, MD, PhD, is the Director of the National Institute of Mental Health (NIMH), the lead federal agency for research on mental disorders. He oversees an extensive research portfolio of basic and clinical research that seeks to transform the understanding and treatment of mental illnesses, paving the way for prevention, recovery, and cure. Dr. Gordon pursued a combined MD-PhD degree at the University of California, San Francisco (UCSF). Upon completion of the dual degree program at UCSF, Dr. Gordon went to Columbia University for his psychiatry residency. He joined the Columbia faculty in 2004 as an assistant professor in the Department of Psychiatry. Dr. Gordon’s research focuses on the analysis of neural activity in mice carrying mutations of relevance to psychiatric disease. His lab studied genetic models of these diseases from an integrative neuroscience perspective, focused on understanding how a given disease mutation leads to a behavioral phenotype across multiple levels of analysis. To this end, he employs a range of systems neuroscience techniques, including in vivo imaging, anesthetized and awake behavioral recordings, and optogenetics, which is the use of light to control neural activity. His research has direct relevance to schizophrenia, anxiety disorders, and depression. In addition to his research, Dr. Gordon was an associate director of the Columbia University/New York State Psychiatric Institute Adult Psychiatry Residency Program, where he directed the neuroscience curriculum and administered research training programs for residents. Dr. Gordon also maintained a general psychiatric practice, caring for patients who suffer from the illnesses he studied in his lab at Columbia. Our host, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can’t imagine life without. To book Gabe for your next event or learn more about him, please visit gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related